Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Weekly Cabazitaxel for Advanced Prostate Cancer
This study is not yet open for participant recruitment.
Verified January 2012 by Spanish Oncology Genito-Urinary Group
Study NCT01518283   Information provided by Spanish Oncology Genito-Urinary Group

First Received on January 17, 2012.   Last Updated on January 21, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hormone Refractory Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
Cabazitaxel 10 mg/m2
Sponsors listed in this trial
Spanish Oncology Genito-Urinary Group


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services